InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Campbell Chad Thomas, Chief Executive Officer. Director active across 1 company, notably Angiodynamics INC. Aggregated, 28 reports have been logged. History available since 14 July 2021. The latest transaction was filed on 22 July 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Campbell Chad Thomas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
6,466 shares0Common StockSEC:0001140361-26-029632:0
2,330 shares@ US$13.820.0058% mcap9.9% of flowCommon StockSEC:0001140361-26-029632:1
16,081 shares0Common StockSEC:0001140361-26-029331:0
2,367 shares@ US$14.140.0060% mcap11.4% of flowCommon StockSEC:0001140361-26-029176:0
1,112 shares@ US$13.510.0027% mcap5.1% of flowCommon StockSEC:0001140361-26-029176:1
359 shares@ US$13.710.0009% mcap1.7% of flowCommon StockSEC:0001140361-26-029176:2
359 shares@ US$8.690.7% of flowCommon StockSEC:0001140361-25-026796:1
395 shares@ US$8.990.8% of flowCommon StockSEC:0001140361-25-026796:2
1,025 shares@ US$8.692.0% of flowCommon StockSEC:0001140361-25-026796:0
26,268 shares0Common StockSEC:0001140361-25-026461:0
6,600 shares0Common StockSEC:0001140361-24-035598:0
359 shares@ US$7.130.6% of flowCommon StockSEC:0001140361-24-034272:0
1,025 shares@ US$7.181.8% of flowCommon StockSEC:0001140361-24-033783:0
12,350 shares0Common StockSEC:0001140361-24-033637:0
8,610 shares0Common StockSEC:0001140361-23-044835:0
3,900 shares0Common StockSEC:0001140361-23-036320:0
359 shares@ US$8.740.7% of flowCommon StockSEC:0001140361-23-036116:0
395 shares@ US$8.650.8% of flowCommon StockSEC:0001140361-23-036116:1
11,384 shares0Common StockSEC:0001140361-23-035730:0
596 shares@ US$9.631.3% of flowCommon StockSEC:0001140361-23-035085:0
279 shares@ US$9.560.6% of flowCommon StockSEC:0001140361-23-035085:1
3,987 shares0Common StockSEC:0001567619-22-014377:0
3,104 shares0Common StockSEC:0001567619-22-013848:0
10,748 shares@ US$16.5954.1% of flowCommon StockSEC:0001567619-21-017999:0
8,210 shares0Common StockSEC:0001567619-21-016025:0
25 of 28 declarations
About Campbell Chad Thomas
Campbell Chad Thomas is Senior Vice President / General Manager. He is associated with Angiodynamics INC, where his listed role is SVP/GM, Vascular Access. The declarant has 25 filings in total, and across the 25 sampled filings, the period runs from 2021-07-23 to 2026-07-21, with the main transaction nature being tax withholding.
